Belén Sopesén Veramendi

She joined PharmaMar in 2005 and is Virology Business Unit Director since 2021. She sits on the Board of Sylentis and is an independent Board member of Biocross SL. Previously, she was Director of Market Research and, between 2015-2018, General Manager and Board Member (2014-2018) of Xylazel. Between 2006 and 2014, she was General Manager of Noscira, a biotechnology company in the group dedicated to R&D. Previously she was Manager and Technical Director of Qualysite Consultores., a company that she co-founded. Previously, she worked in a Contract Research Organisation, Cibest between 1997 and 2001). She belongs to the Spanish Association of Pharmaceutical Medicine, of which she was president from 2013 to 2015, and for 20 years has been on the teaching committee of the Master Course in Clinical Trials Monitoring at the Madrid Professional Association of Pharmacists. She holds a PhD in Pharmacy from the Universidad Complutense de Madrid.